These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

250 related items for PubMed ID: 9124851

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Mechanism of action of tetrandrine, a natural inhibitor of Candida albicans drug efflux pumps.
    Zhang H, Gao A, Li F, Zhang G, Ho HI, Liao W.
    Yakugaku Zasshi; 2009 May; 129(5):623-30. PubMed ID: 19420894
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [Characterization of azole resistance mechanisms in Chilean clinical isolates of Candida albicans].
    Fuentes M, Hermosilla G, Alburquenque C, Falconer MA, Amaro J, Tapia C.
    Rev Chilena Infectol; 2014 Oct; 31(5):511-7. PubMed ID: 25491448
    [Abstract] [Full Text] [Related]

  • 31. The genetic basis of fluconazole resistance development in Candida albicans.
    Morschhäuser J.
    Biochim Biophys Acta; 2002 Jul 18; 1587(2-3):240-8. PubMed ID: 12084466
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Increased mRNA levels of ERG16, CDR, and MDR1 correlate with increases in azole resistance in Candida albicans isolates from a patient infected with human immunodeficiency virus.
    White TC.
    Antimicrob Agents Chemother; 1997 Jul 18; 41(7):1482-7. PubMed ID: 9210670
    [Abstract] [Full Text] [Related]

  • 34. Mechanisms of azole resistance in clinical isolates of Candida glabrata collected during a hospital survey of antifungal resistance.
    Sanguinetti M, Posteraro B, Fiori B, Ranno S, Torelli R, Fadda G.
    Antimicrob Agents Chemother; 2005 Feb 18; 49(2):668-79. PubMed ID: 15673750
    [Abstract] [Full Text] [Related]

  • 35. Transcriptional analyses of antifungal drug resistance in Candida albicans.
    Lyons CN, White TC.
    Antimicrob Agents Chemother; 2000 Sep 18; 44(9):2296-303. PubMed ID: 10952571
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Fcr1p inhibits development of fluconazole resistance in Candida albicans by abolishing CDR1 induction.
    Shen H, An MM, Wang de J, Xu Z, Zhang JD, Gao PH, Cao YY, Cao YB, Jiang YY.
    Biol Pharm Bull; 2007 Jan 18; 30(1):68-73. PubMed ID: 17202662
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.